Kymera Therapeutics, Inc.

Q2 2021 13F Holders

Symbol
KYMR
CUSIP
501575104
Type
Equity
Class
COM
Num filings
115
Total reported value, excl. options
$1.29 B
Manager Report Date Value ($000) Shares Option Type